Technology Solutions

Exco InTouch, Oracle Health Sciences partner on EDC/ePRO system

Tuesday, March 8, 2016

Exco InTouch, a provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, and Oracle Health Sciences have partnered to launch a standardized integration between two “best of breed” solutions to provide a robust, highly integrated electronic data capture (EDC) and electronic patient reported outcomes (ePRO) solution which provides the market with a resource that streamlines workflow processes in clinical research.   

[Read More]

IBM, New York Genome Center partner on open cancer data repository

Monday, March 7, 2016

The New York Genome Center and IBM are collaborating to create a comprehensive and open repository of genetic data to accelerate cancer research and scale access to precision medicine using cognitive insights from IBM Watson. Analyzing this data alongside the medical community’s growing knowledge about cancer could help accelerate the ability of doctors to deliver personalized treatment to individual patients.

[Read More]

CHOP, Seven Bridges form Cavatica for pediatric cancer genomics data

Friday, February 26, 2016

The Children’s Hospital of Philadelphia (CHOP), the lead operations center for the Childhood Brain Tumor Tissue Consortium (CBTTC), and Seven Bridges, a biomedical data analysis company, have announced the joint development of Cavatica, a new cloud-based environment for securely storing, sharing and analyzing large volumes of pediatric cancer patient genomics data. Cavatica will support CHOP’s commitment to the White House Precision Medicine Initiative (PMI) through the newly launched Center for Data Driven Discovery in Biomedicine (D3b), located at CHOP. 

[Read More]

Certara launches Phoenix Technology Services for R&D productivity

Thursday, February 25, 2016

Certara, a global biosimulation technology-enabled drug development company, today announced the introduction of Phoenix Technology Services. These services, led and implemented by Certara’s team of biosimulation (modeling and simulation) experts, include customized and ready-to-use solutions that span the breadth of the Phoenix platform.

[Read More]

Icon releases Flex Advantage for patient randomization

Tuesday, February 2, 2016

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has launched Flex Advantage, a next-generation Interactive Response Technology (IRT) platform that offers enhanced randomization and clinical supply management capabilities and supports the execution of adaptive trials.

[Read More]